We are live on ! Find out more
ADILW

Adial Pharmaceuticals Warrant
ADILW

Delisted

ADILW was delisted on the 27th of July, 2023.

Back to rankings

3 hedge funds and large institutions have $17K invested in Adial Pharmaceuticals Warrant in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

0% more capital invested

Capital invested by funds: $17K → $17K ($0)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$2

Top Sellers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
-$3.72K
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
1
Ameriprise
Minnesota
$14K – – –
WAM
2
Wolverine Asset Management
Illinois
$3K -$3.72K -4,506 -51%
UBS Group
3
UBS Group
Switzerland
– +$2 +2 New

ADILW Hedge Fund Activity: Q3 2021 in Review

3 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q3 2021, worth a combined $17K — unchanged from a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ADILW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $2. The largest seller was Wolverine Asset Management, cutting an estimated $3.72K.

  • 3 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q3 2021, up from 2 in Q2 2021.
  • Funds reported $17K of Adial Pharmaceuticals Warrant stock for Q3 2021, unchanged quarter-over-quarter.
  • 1 fund opened new Adial Pharmaceuticals Warrant positions in Q3 2021 and 0 closed out, a net change of +1 holder.
  • The largest Adial Pharmaceuticals Warrant buyer in Q3 2021 was UBS Group, an estimated $2 added.
  • The largest Adial Pharmaceuticals Warrant seller in Q3 2021 was Wolverine Asset Management, an estimated $3.72K sold.

Based on aggregated 13F filings for Q3 2021.